National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 620870

History of Changes from the VAERS Wayback Machine

First Appeared on 4/14/2017

VAERS ID: 620870
Age:12.0
Gender:Female
Location:Foreign
Vaccinated:2009-05-04
Onset:0000-00-00
Submitted:2016-01-19
Entered:2016-01-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / 0 UN / SYR

Administered by: Other      Purchased by: Other
Symptoms: Abdominal distension, Abdominal pain, Arthralgia, Back pain, Choking sensation, Constipation, Diarrhoea, Dizziness, Dry mouth, Dyskinesia, Dyspnoea, Fatigue, Feeling cold, Headache, Hyperaesthesia, Hyperhidrosis, Hypersensitivity, Increased tendency to bruise, Livedo reticularis, Muscle spasms, Muscle twitching, Muscular weakness, Myalgia, Nausea, Neuralgia, Pain, Palpitations, Peripheral coldness, Photophobia, Presyncope, Seizure, Skin disorder, Skin exfoliation, Visual impairment, Fibromyalgia, General physical health deterioration, Exercise tolerance decreased, Cognitive disorder, Angiopathy, Laboratory test, Postural orthostatic tachycardia syndrome, Body temperature fluctuation, Tilt table test positive

Life Threatening? No
Died? No
Permanent Disability? Yes
Recovered? No
ER or Doctor Visit? No
Hospitalized? Yes, days:     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions: GARDASIL; GARDASIL; GARDASIL; Fibromyalgia; 2011, Infection, Mange; Osteochondrosis, Scheuermann;
Diagnostic Lab Data: Have examinations and/or lab tests been performed: Yes. Pediatric department and Rheumatology department. Pain clinic and Dermatology department. Have examinations and/or lab tests been performed: Yes. Tilt table test at the hospital, meet the diagnosis criteria for POTS.
CDC 'Split Type': DK2016004962

Write-up:This case was reported by a consumer via regulatory authority and described the occurrence of dizziness in a 12-year-old female patient who received ENGERIX B. Co-suspect products included GARDASIL suspension for injection (batch number NK05560, NK05560 OG NK36120, expiry date unknown). The patient''s past medical history included Fibromyalgia, recurrent infection (Mange), Scheuermann''s disease, back pain and skin disorder. In January 2010, the patient received ENGERIX B (intramuscular) 1 dosage forms. On 4th May 2009, the patient received 1st dose of GARDASIL (intramuscular) 1 dosage forms at an unknown frequency. On 23rd June 2009, the patient received 2nd dose of GARDASIL (intramuscular) 1 dosage forms at an unknown frequency. On 20th October 2009, the patient received 3rd dose of GARDASIL (intramuscular) at an unknown dose and frequency. In 2009, not applicable after receiving ENGERIX B, the patient experienced dizziness (serious criteria hospitalization and disability), fatigue (serious criteria hospitalization and disability) and general body pain (serious criteria hospitalization and disability). On 1st December 2009, the patient experienced headache (serious criteria hospitalization and disability). On 1st January 2010, the patient experienced breathlessness (serious criteria hospitalization and disability). In March 2010, the patient experienced marbled skin (serious criteria hospitalization and disability), cold hands and feet (serious criteria hospitalization and disability), nausea (serious criteria hospitalization and disability), allergic reaction (serious criteria hospitalization and disability), cramp (serious criteria hospitalization and disability), hypersensation skin (serious criteria hospitalization and disability) and spontaneous bruising (serious criteria hospitalization and disability). In August 2010, the patient experienced back pain (serious criteria hospitalization and disability) and nerve pain (serious criteria hospitalization and disability). In 2011, the patient experienced visual disturbance (serious criteria hospitalization and disability), localizaed exfoliation (serious criteria hospitalization and disability) and lower extremities weakness of (serious criteria hospitalization and disability). On an unknown date, the patient experienced involuntary muscle movement (serious criteria hospitalization and disability), postural orthostatic tachycardia syndrome (serious criteria hospitalization and disability), joint pain (serious criteria hospitalization and disability), palpitation (serious criteria hospitalization and disability), general physical health deterioration (serious criteria hospitalization and disability), body temperature fluctuation (serious criteria hospitalization and disability), fibromyalgia (serious criteria hospitalization and disability), abdominal pain, bloating (serious criteria hospitalization and disability), cognitive disorder (serious criteria hospitalization and disability), diarrhea (serious criteria hospitalization and disability), dry mouth (serious criteria hospitalization and disability), exercise capacity decreased (serious criteria hospitalization and disability) and eyes sensitive to sunlight (serious criteria hospitalization and disability). On an unknown date, the patient experienced muscle pain (serious criteria hospitalization and disability), presyncope (serious criteria hospitalization and disability), obstipation (serious criteria hospitalization and disability), skin disorder (serious criteria hospitalization and disability) and vascular disorder (serious criteria hospitalization and disability). On an unknown date. the outcome of the dizziness, fatigue, back pain, headache, visual disturbance, general body pain, marbled skin, postural orthostatic tachycardia syndrome, cold hands and feet, nausea, general physical health deterioration, allergic reaction, body temperature fluctuation, breathlessness, choking sensation, cramp, fibromyalgia, hypersensatio


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=620870&WAYBACKHISTORY=ON


Copyright © 2017 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166